Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2012, Article ID 834181, 4 pages
http://dx.doi.org/10.1155/2012/834181
Clinical Study

Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza Patients

Pediatric Division, Hikita Pediatric Clinic, 2-7-20 Nakamachi, Kiryu City, Gunma 376-0035, Japan

Received 30 October 2011; Accepted 16 December 2011

Academic Editor: Lavjay Butani

Copyright © 2012 Toshiyuki Hikita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Defne Arslan, and Lara Danziger-Isakov, “Respiratory Viral Infections in Pediatric Solid Organ and Hematopoietic Stem Cell Transplantation,” Current Infectious Disease Reports, vol. 14, no. 6, pp. 658–667, 2012. View at PublisherView at Google Scholar
  • Andrew J. Burnham, Tatiana Baranovich, and Elena A. Govorkova, “Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance,” Antiviral Research, 2013. View at PublisherView at Google Scholar
  • Rubaiyea Farrukee, Jennifer Mosse, and Aeron C. Hurt, “Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses,” Expert Review of Anti-Infective Therapy, vol. 11, no. 11, pp. 1135–1145, 2013. View at PublisherView at Google Scholar
  • Yuji Takemoto, Teizaburo Asai, Itsuo Ikezoe, Takako Yano, Masahiro Ichikawa, Shogo Miyagawa, and Jun Matsumoto, “Clinical Effects of Oseltamivir, Zanamivir, Laninamivir and Peramivir on Seasonal Influenza Infection in Outpatients in Japan during the Winter of 2012-2013,” Chemotherapy, vol. 59, no. 5, pp. 373–378, 2013. View at PublisherView at Google Scholar
  • Yusuke Yoshino, Kazunori Seo, Ichiro Koga, Takatoshi Kitazawa, and Yasuo Ota, “Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan,” The Clinical Respiratory Journal, 2014. View at PublisherView at Google Scholar
  • Atsuko Hata, Ryoko Akashi-Ueda, Kazufumi Takamatsu, and Takuro Matsumura, “Safety and efficacy of peramivir for influenza treatment.,” Drug design, development and therapy, vol. 8, pp. 2017–38, 2014. View at PublisherView at Google Scholar
  • Shiang-Fen Huang, Chang-Phone Fung, Diahn-Warng Perng, and Fu-Der Wang, “Effects of corticosteroid and neuraminidase inhibitors on survival in patients with respiratory distress induced by influenza virus,” Journal of Microbiology, Immunology and Infection, 2015. View at PublisherView at Google Scholar
  • Malak M. Alame, Elie Massaad, and Hassan Zaraket, “Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections,” Frontiers in Microbiology, vol. 7, 2016. View at PublisherView at Google Scholar
  • Yusuke Yoshino, Kazunori Seo, Ichiro Koga, Takatoshi Kitazawa, and Yasuo Ota, “Clinical efficacy of laninamivir and peramivir in patients with seasonal influenza: a randomized clinical trial,” Infectious Diseases, pp. 1–3, 2016. View at PublisherView at Google Scholar
  • Ashley Wester, and Avinash K Shetty, “Peramivir injection in the treatment of acute influenza: a review of the literature.,” Infection and drug resistance, vol. 9, pp. 201–14, 2016. View at PublisherView at Google Scholar
  • Grant C. Paulsen, and Lara Danziger-Isakov, “Respiratory Viral Infections in Solid Organ and Hematopoietic Stem Cell Transplantation,” Clinics in Chest Medicine, 2017. View at PublisherView at Google Scholar
  • Shigeki Nakamura, Taiga Miyazaki, Koichi Izumikawa, Hiroshi Kakeya, Yutaka Saisho, Katsunori Yanagihara, Yoshitsugu Miyazaki, Hiroshi Mukae, and Shigeru Kohno, “Efficacy and Safety of Intravenous Peramivir Compared With Oseltamivir in High-Risk Patients Infected With Influenza A and B Viruses: A Multicenter Randomized Controlled Study.,” Open forum infectious diseases, vol. 4, no. 3, 2017. View at PublisherView at Google Scholar
  • Jonghoo Lee, Ju-Hee Park, Hyeyoung Jwa, and Yee Hyung Kim, “Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis,” Yonsei Medical Journal, vol. 58, no. 4, pp. 778, 2017. View at PublisherView at Google Scholar
  • Nobuhisa Ishiguro, Naoko Koseki, Miki Kaiho, Tadashi Ariga, Hideaki Kikuta, Koji Oba, Takehiro Togashi, Keisuke Morita, Akira Inagawa, Akiko Okamura, Shigeru Yamazaki, Satoru Shida, Mutsuko Konno, Nobuaki Kawamura, Akihito Ishizaka, Kimihiko Takada, Keiji Tsubakihara, Naoko Nagano, Mutsuo Shibata, Hideto Furuyama, Yoshihiro Matsuzono, Akemi Koike, Mari Murashita, Yoshio Hatae, Hideki Arioka, Tatsuru Yamanaka, Toru Watanabe, Yuuichi Tabata, Yoshihiro Kumita, Kyosuke Hazama, Yasushi Akutsu, Hayato Aoyagi, Chie Tobise, Katsuki Azuma, Kohichi Yasoshima, Yoko Sawada, Kazuyuki Uetsuji, Akira Tsuchida, Akira Tsuchiyama, Kazue Yasuda, Yasuhisa Odagawa, and Mikio Yoshioka, “Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014–2015 to 2016–2017 influenza seasons in Japan,” Journal of Infection and Chemotherapy, 2018. View at PublisherView at Google Scholar
  • David W. Kimberlin, “Antiviral Agents,” Principles and Practice of Pediatric Infectious Diseases, pp. 1551–1567.e6, 2018. View at PublisherView at Google Scholar